+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzyme-linked Immunosorbent Assay Testing Market by Product, Assay Type, End Users, Application - Global Forecast to 2030- Product Image
Enzyme-linked Immunosorbent Assay Testing Market by Product, Assay Type, End Users, Application - Global Forecast to 2030- Product Image
Sale

Enzyme-linked Immunosorbent Assay Testing Market by Product, Assay Type, End Users, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989693
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The enzyme-linked immunosorbent assay (ELISA) testing market is evolving rapidly, driven by increasing demand across healthcare, research, and diagnostics. This report provides senior decision-makers with clear analysis, highlighting critical factors shaping the landscape and supporting growth planning in a competitive environment.

Market Snapshot: Enzyme-linked Immunosorbent Assay Testing Market

The enzyme-linked immunosorbent assay testing market grew from USD 552.58 million in 2024 to USD 593.09 million in 2025. It is expected to continue growing at a CAGR of 7.13%, reaching USD 835.38 million by 2030. This strong trajectory reflects consistent advances in assay technologies, rising healthcare spending, and uptake in decentralized testing environments. Market expansion is propelled by wider adoption in disease diagnostics, drug discovery, and environmental monitoring, and the entry of regional players challenging established brands through innovation and tailored solutions.

Scope & Segmentation of the ELISA Testing Market

  • Product Segments: Instruments (microplate readers, microplate washers), kits (automated and manual), reagents (antibodies, enzymes, substrates), software and services (data analysis, maintenance services).
  • Assay Types: Competitive, direct, indirect, and sandwich formats addressing varied testing needs.
  • End Users: Academic and research institutions, contract research organizations, hospitals and diagnostics labs, pharmaceutical and biotechnology companies.
  • Applications: Disease testing, drug discovery, environmental monitoring, and food safety and quality assurance.
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, United Arab Emirates, South Africa, and others), and Asia-Pacific (such as China, India, Japan, Australia, South Korea, Singapore, and more).
  • Technologies: Automation, cloud-based data analysis, point-of-care ELISA platforms, multiplexing, machine learning, miniaturization, and advanced reagent formulations.
  • Leading Companies: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories, Agilent Technologies, PerkinElmer, Bio-Techne Corporation, Becton, Dickinson and Company, Abcam, and Enzo Biochem.

Key Takeaways for Strategic Decision-Makers

  • Innovation cycles in automation and cloud integration are redefining ELISA workflows, supporting higher throughput and better data connectivity between sites and partners.
  • Product differentiation through high-affinity reagents and modular assay kits is becoming essential as competition intensifies and customers emphasize flexibility and precision.
  • Adoption is accelerating in emerging markets, especially where investments target laboratory modernization and regulatory harmonization.
  • Software and service segments—covering analytics, maintenance, and workflow optimization—are central to delivering value beyond core assay consumables.
  • Decentralized and point-of-care formats are opening opportunities in public health and on-site monitoring, reshaping traditional procurement and support models.
  • Collaborations, both within diagnostics technology and data analytics, are driving new partnerships, while startups focusing on digital and multiplex assay formats are prompting incumbents to adapt rapidly.

Tariff Impact on ELISA Supply Chains

Recent adjustments to U.S. tariffs have raised complexities in the sourcing of assay instruments and reagents. This has prompted market participants to revisit procurement strategies by securing long-term supply agreements, diversifying sources, and investing in local manufacturing where feasible. The shift in trade policy is also influencing pricing and has increased the value of agile logistics partnerships and localized support services, especially as border inspection times fluctuate and input costs vary across regions.

Methodology & Data Sources

This report draws on structured interviews with sector opinion leaders and practitioners, combined with an exhaustive review of published scientific articles, industry reports, patent filings, and regulatory databases. Data triangulation was applied to validate all findings for accuracy and consistency.

Why This Report Matters

  • Enables robust growth planning, helping stakeholders identify high-potential applications, evolving user preferences, and regional drivers.
  • Supports risk management and supply strategy through actionable insights on tariff implications, procurement trends, and production shifts.
  • Equips senior executives with competitive intelligence to inform partnership, investment, and R&D priorities in this dynamic market.

Conclusion

The enzyme-linked immunosorbent assay testing market is experiencing multidimensional growth shaped by technology, policy dynamics, and targeted innovation. Clear, data-driven insights empower leadership teams to chart resilient strategies and seize new market opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Enzyme-linked Immunosorbent Assay Testing Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Microplate Readers
8.2.2. Microplate Washers
8.3. Kits
8.3.1. Automated Kits
8.3.2. Manual Kits
8.4. Reagents
8.4.1. Antibodies
8.4.2. Enzymes
8.4.3. Substrates
8.5. Software and Services
8.5.1. Data Analysis Software
8.5.2. Maintenance Services
9. Enzyme-linked Immunosorbent Assay Testing Market, by Assay Type
9.1. Introduction
9.2. Competitive
9.3. Direct
9.4. Indirect
9.5. Sandwich
10. Enzyme-linked Immunosorbent Assay Testing Market, by End Users
10.1. Introduction
10.2. Academic and Research
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostics
10.5. Pharmaceutical and Biotech
11. Enzyme-linked Immunosorbent Assay Testing Market, by Application
11.1. Introduction
11.2. Disease Testing
11.3. Drug Discovery
11.4. Environmental Testing
11.5. Food Safety and Quality
12. Americas Enzyme-linked Immunosorbent Assay Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Merck KGaA
15.3.4. Bio-Rad Laboratories, Inc.
15.3.5. Agilent Technologies, Inc.
15.3.6. PerkinElmer, Inc.
15.3.7. Bio-Techne Corporation
15.3.8. Becton, Dickinson and Company
15.3.9. Abcam plc
15.3.10. Enzo Biochem, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET MULTI-CURRENCY
FIGURE 2. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE WASHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY FOOD SAFETY AND QUALITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 60. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 61. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 62. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 64. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 111. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 112. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 113. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 132. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 133. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 134. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 135. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 137. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 143. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 145. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 175. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 176. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 177. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 188. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 189. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 190. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 191. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 193. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 199. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 201. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 223. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 224. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 231. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 232. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 233. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 247. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 253. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 254. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 255. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 257. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 278. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 279. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 280. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 281. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 282. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. INDIA ENZYME-LINKED IMMUNOSORBENT ASS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Enzyme-linked Immunosorbent Assay Testing market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation
  • Becton, Dickinson and Company
  • Abcam plc
  • Enzo Biochem, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 593.09 Million
Forecasted Market Value ( USD ) by 2030 $ 835.38 Million
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Enzyme-linked Immunosorbent Assays (ELISAs) Market Report and Forecast 2024-2032 - Product Image

Enzyme-linked Immunosorbent Assays (ELISAs) Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay Testing Market Report 2025 - Product Image

Enzyme-Linked Immunosorbent Assay Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Strategic Business Report - Product Image

Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Enzyme Linked Immunosorbent Assay Test Market

The Enzyme Linked Immunosorbent Assay (ELISA) Test is a type of In Vitro Diagnostics (IVD) test used to detect and measure the presence of antibodies, antigens, and other proteins in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of hormones, toxins, and other substances in the body. The ELISA Test market is a rapidly growing segment of the IVD market. ELISA tests are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. The market is driven by the increasing demand for accurate and reliable diagnostic tests, as well as the development of new technologies and products. Some of the major companies in the ELISA Test market include Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.